103 related articles for article (PubMed ID: 16149135)
1. Expression liver-directed genes by employing synthetic transcriptional control units.
Lemken ML; Wybranietz WA; Schmidt U; Graepler F; Armeanu S; Bitzer M; Lauer UM
World J Gastroenterol; 2005 Sep; 11(34):5295-302. PubMed ID: 16149135
[TBL] [Abstract][Full Text] [Related]
2. Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma.
Lu SY; Sui YF; Li ZS; Pan CE; Ye J; Wang WY
World J Gastroenterol; 2003 Apr; 9(4):688-91. PubMed ID: 12679911
[TBL] [Abstract][Full Text] [Related]
3. Interaction of hepatocyte nuclear factors in transcriptional regulation of tissue specific hormonal expression of human multidrug resistance-associated protein 2 (abcc2).
Qadri I; Hu LJ; Iwahashi M; Al-Zuabi S; Quattrochi LC; Simon FR
Toxicol Appl Pharmacol; 2009 Feb; 234(3):281-92. PubMed ID: 19010343
[TBL] [Abstract][Full Text] [Related]
4. An efficient and safe herpes simplex virus type 1 amplicon vector for transcriptionally targeted therapy of human hepatocellular carcinomas.
Lam PY; Sia KC; Khong JH; De Geest B; Lim KS; Ho IA; Wang GY; Miao LV; Huynh H; Hui KM
Mol Ther; 2007 Jun; 15(6):1129-36. PubMed ID: 17426711
[TBL] [Abstract][Full Text] [Related]
5. Activation of nicotinamide N-methyltransferase gene promoter by hepatocyte nuclear factor-1beta in human papillary thyroid cancer cells.
Xu J; Capezzone M; Xu X; Hershman JM
Mol Endocrinol; 2005 Feb; 19(2):527-39. PubMed ID: 15486044
[TBL] [Abstract][Full Text] [Related]
6. Cell-specific expression of artificial microRNAs targeting essential genes exhibit potent antitumor effect on hepatocellular carcinoma cells.
Mao C; Liu H; Chen P; Ye J; Teng L; Jia Z; Cao J
Oncotarget; 2015 Mar; 6(8):5707-19. PubMed ID: 25691059
[TBL] [Abstract][Full Text] [Related]
7. Functional promoter testing using a modified lentiviral transfer vector.
Geller SF; Ge PS; Visel M; Greenberg KP; Flannery JG
Mol Vis; 2007 May; 13():730-9. PubMed ID: 17563724
[TBL] [Abstract][Full Text] [Related]
8. [Effects of human telomerase reverse transcriptase promoter and survivin promoter in targeted tumor gene therapy].
Zhang Y; Ma H; Liu SL; Liu YX; Zheng DX
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(7):475-9. PubMed ID: 18642790
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
[TBL] [Abstract][Full Text] [Related]
10. Robust prostate-specific expression for targeted gene therapy based on the human kallikrein 2 promoter.
Xie X; Zhao X; Liu Y; Young CY; Tindall DJ; Slawin KM; Spencer DM
Hum Gene Ther; 2001 Mar; 12(5):549-61. PubMed ID: 11268287
[TBL] [Abstract][Full Text] [Related]
11. Chimeric transcriptional control units for improved liver-specific transgene expression.
Gehrke S; Jérôme V; Müller R
Gene; 2003 Dec; 322():137-43. PubMed ID: 14644505
[TBL] [Abstract][Full Text] [Related]
12. Cloning and characterization of the human beta2-glycoprotein I (beta2-GPI) gene promoter: roles of the atypical TATA box and hepatic nuclear factor-1alpha in regulating beta2-GPI promoter activity.
Wang HH; Chiang AN
Biochem J; 2004 Jun; 380(Pt 2):455-63. PubMed ID: 14984368
[TBL] [Abstract][Full Text] [Related]
13. Combined radionuclide-chemotherapy and in vivo imaging of hepatocellular carcinoma cells after transfection of a triple-gene construct, NIS, HSV1-sr39tk, and EGFP.
Lee YL; Lee YJ; Ahn SJ; Choi TH; Moon BS; Cheon GJ; Lee SW; Ahn BC; Ha JH; Lee J
Cancer Lett; 2010 Apr; 290(1):129-38. PubMed ID: 19819065
[TBL] [Abstract][Full Text] [Related]
14. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Cyp2a5 transcription in mouse primary hepatocytes: roles of hepatocyte nuclear factor 4 and nuclear factor I.
Ulvila J; Arpiainen S; Pelkonen O; Aida K; Sueyoshi T; Negishi M; Hakkola J
Biochem J; 2004 Aug; 381(Pt 3):887-94. PubMed ID: 15115437
[TBL] [Abstract][Full Text] [Related]
16. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
[TBL] [Abstract][Full Text] [Related]
17. Human thyroxine-binding globulin gene: complete sequence and transcriptional regulation.
Hayashi Y; Mori Y; Janssen OE; Sunthornthepvarakul T; Weiss RE; Takeda K; Weinberg M; Seo H; Bell GI; Refetoff S
Mol Endocrinol; 1993 Aug; 7(8):1049-60. PubMed ID: 8232304
[TBL] [Abstract][Full Text] [Related]
18. Specific expression and promoter analysis of the albumin gene promoter of the duck (Anas platyrhynchos domesticus).
Chen Y; Yu Q; Huang Z; Wang B; Xu Q; Lan L; Chang G; Zhang Y; Chen G
Br Poult Sci; 2017 Feb; 58(1):19-25. PubMed ID: 27844479
[TBL] [Abstract][Full Text] [Related]
19. A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma.
Zeng C; Wang R; Li D; Lin XJ; Wei QK; Yuan Y; Wang Q; Chen W; Zhuang SM
Hepatology; 2010 Nov; 52(5):1702-12. PubMed ID: 21038412
[TBL] [Abstract][Full Text] [Related]
20. Selective tropism of liver stem cells to hepatocellular carcinoma in vivo.
Zhong XG; He S; Yin W; Deng JY; Cheng B
World J Gastroenterol; 2007 Jul; 13(28):3886-91. PubMed ID: 17657848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
